SG Americas Securities’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
101,920
-163
-0.2% -$1.75K ﹤0.01% 1642
2026
Q1
$864K Sell
102,083
-3,435
-3% -$37.6K ﹤0.01% 1861
2025
Q4
$1.19M Buy
105,518
+78,585
+292% +$974K ﹤0.01% 1869
2025
Q3
$404K Buy
26,933
+13,869
+106% +$202K ﹤0.01% 2271
2025
Q2
$184K Sell
13,064
-9,965
-43% -$178K ﹤0.01% 2303
2025
Q1
$554K Buy
23,029
+14,028
+156% +$495K ﹤0.01% 1690
2024
Q4
$336K Sell
9,001
-7,529
-46% -$351K ﹤0.01% 1685
2024
Q3
$826K Sell
16,530
-8,725
-35% -$339K ﹤0.01% 1235
2024
Q2
$877K Buy
25,255
+13,485
+115% +$533K 0.01% 1370
2024
Q1
$644K Buy
+11,770
New +$583K ﹤0.01% 1313
2023
Q3
Sell
-4,267
Closed -$102K 3106
2023
Q2
$102K Sell
4,267
-16,014
-79% -$276K ﹤0.01% 2080
2023
Q1
$277K Buy
+20,281
New +$323K ﹤0.01% 2180

Other funds holding BHVN

SG Americas Securities's BHVN Position: Q2 2026 in Review

SG Americas Securities reduced its Biohaven (BHVN) stake by 0.16% in Q2 2026, selling an estimated $1.75K and leaving 101,920 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

SG Americas Securities first reported a position in BHVN in Q1 2023 and has held it in 12 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • SG Americas Securities held 101,920 shares of Biohaven worth $1.52M as of Q2 2026.
  • SG Americas Securities sold 163 Biohaven shares in Q2 2026, an estimated $1.75K.
  • Biohaven made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1642 holding.
  • SG Americas Securities first reported a position in Biohaven in Q1 2023 and has held it in 12 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.